As #AI tools become part of routine #neuroradiology practice, clarity on regulation, liability, and reimbursement is essential for confident, sustainable adoption. That is the focus of our next American Society of Neuroradiology (#ASNR) AI Committee Webinar this Friday. 🧠 "Regulatory, Medical-Legal, and Reimbursement Considerations for AI Tools in Clinical Practice" 📅 Friday, September 18 | 12pm PT / 3pm ET 🔗 Register here: ow.ly/abnN50ZKHVE I'm delighted to co-moderate with @ryankleemd, joined by two outstanding speakers, @MelissaChenM and @OrmsbyMD. We will cover: 🔹 FDA clearance pathways, including indications for use and oversight of algorithm changes after market entry 🔹 Liability and documentation: the evolving standard of care and how responsibility is allocated among vendors, institutions, and interpreting radiologists 🔹 Mitigating bias in training data and validation design, performance across patient populations, and monitoring for drift after deployment 🔹 Privacy obligations, HIPAA, de-identification, and patient data use for model training 🔹 Reimbursement: CPT coding categories, add-on payment mechanisms, payer coverage, and return on investment The session concludes with a panel discussion and live Q&A, so bring your questions. 🫶 1 AMA PRA Category 1 Credit™ is available, and ASNR membership is not required to attend. I look forward to seeing you there!